NTAP
45
2
MS
76
2
PX
55
-3
FLR
36
3
NOC
69
6
RF
73
-3
FTI
74
3
ABT
47
-3
VIX
30
-8
PG
32
4
DE
50
-5
HD
35
7
ADM
68
3
UA
47
-9
STX
78
5
CINF
58
-5
TEL
80
5
VRTX
60
-4
ETR
54
7
XEL
60
7
NTAP
45
2
MS
76
2
PX
55
-3
FLR
36
3
NOC
69
6
RF
73
-3
FTI
74
3
ABT
47
-3
VIX
30
-8
PG
32
4
DE
50
-5
HD
35
7
ADM
68
3
UA
47
-9
STX
78
5
CINF
58
-5
TEL
80
5
VRTX
60
-4
ETR
54
7
XEL
60
7
Financhill
Back

Structure Therapeutics, Inc. Stock Predictions

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
77

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.66
Seasonality Move:
-21.79%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Structure Therapeutics, Inc. Stock Forecast

  • Over the next 52 weeks, Structure Therapeutics, Inc. has on average historically risen by 54.3% based on the past 2 years of stock performance.
  • Structure Therapeutics, Inc. has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Structure Therapeutics, Inc. Stock Undervalued?
    The current Structure Therapeutics, Inc. [GPCR] share price is $68.61. The Score for GPCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Structure Therapeutics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Structure Therapeutics, Inc. has on average historically risen by 54.3% based on the past 2 years of stock performance.

Structure Therapeutics, Inc. Stock Rating

Buy
77
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. overpriced?

  • Structure Therapeutics, Inc. has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Structure Therapeutics, Inc. Stock Price History

Is GPCR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
structuretx.com

52-Week Data

52-Week High:
94.90
52-Week Low:
13.22

Prediction Charts

Market Cap:
4B
Price in USD:
68.61
Volume:
1.1M
Beta:
-2.12

Technical Analysis

SMA50:
48.15
SMA100:
36.06
SMA200:
28.38
52-Wk Change:
153.74%

Stock Predictions

  • Is Structure Therapeutics, Inc. stock public?
    Yes, Structure Therapeutics, Inc. is a publicly traded company.
  • What is the Structure Therapeutics, Inc. stock quote today?
    The Structure Therapeutics, Inc. stock price is 68.61 USD today.
  • How to buy Structure Therapeutics, Inc. stock online?
    You can buy Structure Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 60.25 62.45 62.95 59.58
Dec-19 66.03 64.94 69.30 64.30
Dec-22 64.91 63.25 65.77 61.87
Dec-23 63.21 71.29 71.75 63.21
Dec-24 71.00 69.69 72.00 68.66
Dec-26 69.69 68.34 69.69 67.25
Dec-29 68.00 67.38 68.92 66.58
Dec-30 67.23 67.78 68.88 66.80
Dec-31 67.70 69.55 69.63 67.34
Jan-5 68.15 62.77 68.25 61.99
Jan-6 63.40 63.24 68.09 62.01
Jan-7 63.67 66.25 67.55 63.45
Jan-8 65.91 66.98 67.51 65.48
Jan-9 66.64 68.61 69.78 66.59

Structure Therapeutics, Inc. Earnings

Structure Therapeutics, Inc. Earnings Report: Per Share Structure Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Structure Therapeutics, Inc. Forecast Revenue Growth

Structure Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.34 per share.

* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.